http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015147575-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e9bca1120ab9d2f65b138f53e3eda4d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-344
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
filingDate 2015-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ded5bc6c86e3731c7a5179050aad51cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0c952df7efaae854db4d7b5e3bf3314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8be31d2c32b60b330bd2e5ddf61aba6
publicationDate 2015-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2015147575-A1
titleOfInvention Pharmaceutical composition for treating erectile dysfunction, containing trpc4 inhibitor as active ingredient
abstract The present invention relates to a method for screening an erectile dysfunction medicine candidate, the method comprising a step of measuring the inhibition of TRPC4 activity; and a pharmaceutical composition for treating erectile dysfunction, containing a TRPC4 inhibitor as an active ingredient. The present invention can effectively screen an erectile dysfunction medicine candidate by using a method for measuring TRPC4 activity. The TRPC4 activity inhibitor of the present invention is very effective in relieving the syndrome of erectile dysfunction, and thus can be developed for an erectile dysfunction medicine.
priorityDate 2014-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100135619-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110016591-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226503073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128929316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4199023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394037
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13013858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421630
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20339310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434160

Total number of triples: 46.